Pharmanutra S.p.A. (BIT:PHN)

Market Cap	717.36M +39.4%
Revenue (ttm)	133.97M +15.3%
Net Income	20.00M +20.4%
EPS	2.09 +20.9%
Shares Out	9.60M
PE Ratio	35.74
Forward PE	29.40
Dividend	1.20 (1.58%)
Ex-Dividend Date	May 5, 2025

Volume	17,422
Average Volume	33,673
Open	75.70
Previous Close	75.80
Day's Range	74.60 - 76.30
52-Week Range	38.75 - 77.00
Beta	0.30
RSI	66.32
Earnings Date	May 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 136
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2025, Pharmanutra's revenue was 133.97 million, an increase of 15.34% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.43%.